Top Markets
Coin of the day
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
株式のランク #27070
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
株価
$2.04
最終同期: 2025-12-09
時価総額
$35.38M
変化(1日)
0.00%
変化(1年)
-2.39%
IE
取引 Mural Oncology plc (MURA)

カテゴリー

Mural Oncology plc(MURA)の株価履歴
終値の最高値: $2.04 (2025-12-01)

終値の最安値: $3.85 (2023-11-01)
Mural Oncology plc の株価履歴(2023 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 1.79%
2025 -42.95%
2024 -13.07%
2023 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$760.05 6.79%
CH